A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)
about
A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Clinical Trial to Evaluate t ...... vir/Cobicistat (TAF/FTC/DRV/c)
@en
type
label
A Clinical Trial to Evaluate t ...... vir/Cobicistat (TAF/FTC/DRV/c)
@en
prefLabel
A Clinical Trial to Evaluate t ...... vir/Cobicistat (TAF/FTC/DRV/c)
@en
P4844
P1476
Phase IV, Open Label, Randomiz ...... icitabine/Darunavir/Cobicistat
@en
P17
P1813
DETOX
@en
P3098
NCT03685500
P580
2018-10-15T00:00:00Z
P582
2019-02-15T00:00:00Z